Immunocore Holdings Ltd (IMCR) — Long-term Investment Intensity

Latest as of March 2023: 1.3%

Immunocore Holdings Ltd (IMCR) has a Long-term Investment Intensity of 1.3% as of March 2023. Long-term investments of $7.03 Million represent 1.3% of total assets of $532.33 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check IMCR capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

1.3%
LT Investments / Total Assets

Long-term Investments

$7.03 Million
USD

Total Assets

$532.33 Million
USD

Country

USA
NASDAQ

Immunocore Holdings Ltd Long-term Investment Intensity (2019–2022)

This chart shows how Immunocore Holdings Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2019 to 2022. As of March 2023, the intensity stands at 1.3%, reflecting long-term investments of $7.03 Million against total assets of $532.33 Million USD. Explore IMCR operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for Immunocore Holdings Ltd (2019–2022)

The table below presents the year-by-year Long-term Investment Intensity for Immunocore Holdings Ltd from 2019 to 2022, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Immunocore Holdings Ltd (IMCR) total market value.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2022 0.0% $137.00K $526.76 Million ▼ 0.0 pp
2021 0.0% $165.00K $407.28 Million ▼ -0.5 pp
2020 0.5% $973.00K $197.19 Million ▲ +0.3 pp
2019 0.2% $591.00K $245.94 Million
pp = percentage points